These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 9661966)

  • 61. Anticonvulsant action of a NMDA receptor antagonist CGP 40116 varies only quantitatively during ontogeny in rats.
    Haugvicová R; Mares P
    Fundam Clin Pharmacol; 1998; 12(5):521-5. PubMed ID: 9794150
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Excitatory amino acid antagonists and pentylenetetrazol-induced seizures during ontogenesis. IV. Effects of CGP 39551.
    Velísek L; Vachová D; Mares P
    Pharmacol Biochem Behav; 1997 Mar; 56(3):493-8. PubMed ID: 9077588
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Felbamate and meprobamate: a comparison of their anticonvulsant properties.
    Frey HH; Bartels I
    Epilepsy Res; 1997 Jun; 27(3):151-64. PubMed ID: 9237049
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Effects of flunarizine on Metrazol-induced seizures in developing rats.
    Pohl M; Mares P
    Epilepsy Res; 1987 Sep; 1(5):302-5. PubMed ID: 3504406
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Felbamate: a long-term study in subjects with refractory epilepsy].
    De Romanis F; Sopranzi N
    Clin Ter; 1997 Mar; 148(3):83-7. PubMed ID: 9377844
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Anticonvulsant action of 2-chloroadenosine against pentetrazol-induced seizures in immature rats is due to activation of A1 adenosine receptors.
    Mareš P
    J Neural Transm (Vienna); 2010 Nov; 117(11):1269-77. PubMed ID: 20809069
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Ethosuximide suppresses seizures and lethality induced by picrotoxin in developing rats.
    Velísková J; Velísek L; Mares P; Rokyta R; Micianiková D
    Pharmacol Biochem Behav; 1993 Apr; 44(4):975-9. PubMed ID: 8469708
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Felbamate demonstrates low propensity for interaction with methylxanthines and Ca2+ channel modulators against experimental seizures in mice.
    Gasior M; Swiader M; Przybyłko M; Borowicz K; Turski WA; Kleinrok Z; Czuczwar SJ
    Eur J Pharmacol; 1998 Jul; 352(2-3):207-14. PubMed ID: 9716356
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Anticonvulsant effects of phencynonate hydrochloride and other anticholinergic drugs in soman poisoning: neurochemical mechanisms.
    Wang YA; Zhou WX; Li JX; Liu YQ; Yue YJ; Zheng JQ; Liu KL; Ruan JX
    Life Sci; 2005 Nov; 78(2):210-23. PubMed ID: 16154160
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Population pharmacokinetics of felbamate in children.
    Kelley MT; Walson PD; Cox S; Dusci LJ
    Ther Drug Monit; 1997 Feb; 19(1):29-36. PubMed ID: 9029743
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Changes of the EEG paroxysmal pattern during felbamate therapy in Lennox-Gastaut syndrome: a case report.
    Marciani MG; Spanedda F; Placidi F; Bassetti MA; Romigi A; Mattia D
    Int J Neurosci; 1998 Sep; 95(3-4):247-53. PubMed ID: 9777442
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Anticonvulsant profile of flunarizine and relation to Na(+) channel blocking effects.
    Fischer W; Kittner H; Regenthal R; De Sarro G
    Basic Clin Pharmacol Toxicol; 2004 Feb; 94(2):79-88. PubMed ID: 14748851
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Antagonism of convulsions but failure to enhance GABA(A) receptor function by felbamate in mice tolerant to diazepam.
    Serra M; Cuccu R; Ghiani CA; Pisu MG; Murgia A; Biggio G
    Neurochem Res; 1997 Jun; 22(6):693-7. PubMed ID: 9178952
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Efficacy of felbamate monotherapy in patients undergoing presurgical evaluation of partial seizures.
    Devinsky O; Faught RE; Wilder BJ; Kanner AM; Kamin M; Kramer LD; Rosenberg A
    Epilepsy Res; 1995 Mar; 20(3):241-6. PubMed ID: 7796796
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Felbamate, a novel antiepileptic drug, reverses N-methyl-D-aspartate/glycine-stimulated increases in intracellular Ca2+ concentration.
    Taylor LA; McQuade RD; Tice MA
    Eur J Pharmacol; 1995 Apr; 289(2):229-33. PubMed ID: 7621896
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Neuroprotective effect of felbamate after kainic acid-induced status epilepticus.
    Chronopoulos A; Stafstrom C; Thurber S; Hyde P; Mikati M; Holmes GL
    Epilepsia; 1993; 34(2):359-66. PubMed ID: 8453945
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Felbamate: a double-blind controlled trial in patients undergoing presurgical evaluation of partial seizures.
    Bourgeois B; Leppik IE; Sackellares JC; Laxer K; Lesser R; Messenheimer JA; Kramer LD; Kamin M; Rosenberg A
    Neurology; 1993 Apr; 43(4):693-6. PubMed ID: 8469324
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Anticonvulsant activity of β-caryophyllene against pentylenetetrazol-induced seizures.
    de Oliveira CC; de Oliveira CV; Grigoletto J; Ribeiro LR; Funck VR; Grauncke AC; de Souza TL; Souto NS; Furian AF; Menezes IR; Oliveira MS
    Epilepsy Behav; 2016 Mar; 56():26-31. PubMed ID: 26827298
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Ketamine suppresses both bicuculline- and picrotoxin-induced generalized tonic-clonic seizures during ontogenesis.
    Velísková J; Velísek L; Mares P; Rokyta R
    Pharmacol Biochem Behav; 1990 Dec; 37(4):667-74. PubMed ID: 2093170
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Long-term use of felbamate: clinical outcomes and effect of age and concomitant antiepileptic drug use on its clearance.
    White JR; Leppik IE; Beattie JL; Walczak TS; Tran TA; Rarick JO; Vaher P
    Epilepsia; 2009 Nov; 50(11):2390-6. PubMed ID: 19563346
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.